BIOXXMED AG INH O.N.BIOXXMED AG INH O.N.BIOXXMED AG INH O.N.

BIOXXMED AG INH O.N.

No trades
See on Supercharts

T5O0 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

bioXXmed AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept. The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
T5O0 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company